Movement Alert|SUNNY OPTICAL Falls 3.24% in Regular Trading, Subsidiary Sunny Evotech Second IPO Filing Reveals Automotive Margin Pressure

Market Focus
Sep 08

On September 8, SUNNY OPTICAL fell 3.24% in regular trading, trading at 67.25 HKD/share, with turnover of 2.37 billion HKD.

On the news front, subsidiary Sunny Evotech recently re-filed its listing application with the Hong Kong Stock Exchange, with the updated prospectus revealing persistent weakness in automotive business profitability. Despite holding a global leadership position in automotive cameras, the company has suffered four consecutive periods of gross margin decline, as industry-wide price competition continues to erode earnings power. For the first half of the year, Sunny Evotech recorded approximately 3.7 billion RMB in revenue, reflecting a pattern of growing revenue without corresponding profit growth.

Market concerns have also intensified around corporate governance issues. SUNNY OPTICAL, as the controlling shareholder, has served as Sunny Evotech's top supplier since fiscal year-end, raising ongoing questions about the fairness of related-party transaction pricing. Major brokerages remain divided on SUNNY OPTICAL's outlook — Citi maintains a Buy rating with a 94 HKD target, while Daiwa targets 73 HKD with an Outperform rating, citing strength in XR and AI-driven growth strategies.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10